Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.7 - $1.4 $18,580 - $37,161
-26,544 Closed
0 $0
Q1 2022

Jun 30, 2022

SELL
$0.63 - $1.59 $36,355 - $91,754
-57,707 Reduced 68.49%
26,544 $34,000
Q4 2021

Feb 15, 2022

BUY
$1.27 - $2.42 $4,464 - $8,506
3,515 Added 4.35%
84,251 $107,000
Q3 2021

Oct 29, 2021

BUY
$2.15 - $3.82 $653 - $1,161
304 Added 0.38%
80,736 $176,000
Q2 2021

Aug 16, 2021

BUY
$2.89 - $4.45 $193,985 - $298,697
67,123 Added 504.34%
80,432 $302,000
Q4 2020

Feb 12, 2021

BUY
$3.38 - $5.14 $273 - $416
81 Added 0.61%
13,309 $45,000
Q3 2020

Oct 30, 2020

BUY
$2.99 - $4.9 $7,155 - $11,725
2,393 Added 22.09%
13,228 $54,000
Q2 2020

Aug 10, 2020

SELL
$2.11 - $3.38 $20,671 - $33,113
-9,797 Reduced 47.48%
10,835 $37,000
Q1 2020

May 13, 2020

SELL
$1.83 - $3.45 $1,515 - $2,856
-828 Reduced 3.86%
20,632 $48,000
Q4 2019

Feb 13, 2020

BUY
$3.5 - $10.35 $3,440 - $10,174
983 Added 4.8%
21,460 $78,000
Q3 2019

Nov 13, 2019

SELL
$7.03 - $9.7 $1,349 - $1,862
-192 Reduced 0.93%
20,477 $170,000
Q2 2019

Aug 14, 2019

BUY
$7.36 - $11.26 $33,186 - $50,771
4,509 Added 27.9%
20,669 $178,000
Q1 2019

May 15, 2019

BUY
$9.08 - $11.84 $4,821 - $6,287
531 Added 3.4%
16,160 $173,000
Q4 2018

Feb 15, 2019

BUY
$6.39 - $16.99 $99,869 - $265,536
15,629 New
15,629 $137,000
Q3 2018

Nov 14, 2018

SELL
$16.52 - $24.82 $260,768 - $391,783
-15,785 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$14.31 - $21.75 $50,199 - $76,299
3,508 Added 28.57%
15,785 $331,000
Q1 2018

May 22, 2018

SELL
$16.09 - $23.07 $2,510 - $3,598
-156 Reduced 1.25%
12,277 $198,000
Q4 2017

Feb 13, 2018

BUY
$13.36 - $20.73 $27,000 - $41,895
2,021 Added 19.41%
12,433 $236,000
Q3 2017

Nov 09, 2017

BUY
$8.75 - $14.07 $91,105 - $146,496
10,412
10,412 $146,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.